Compare GERN & GNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GERN | GNK |
|---|---|---|
| Founded | 1990 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.3M | 732.0M |
| IPO Year | 1996 | 2005 |
| Metric | GERN | GNK |
|---|---|---|
| Price | $1.38 | $18.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $3.00 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 6.8M | 584.5K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 7.79% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $183,403,000.00 | ★ $331,332,000.00 |
| Revenue This Year | $147.34 | N/A |
| Revenue Next Year | $39.11 | $4.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 522.13 | N/A |
| 52 Week Low | $1.04 | $11.20 |
| 52 Week High | $4.05 | $19.60 |
| Indicator | GERN | GNK |
|---|---|---|
| Relative Strength Index (RSI) | 64.29 | 49.70 |
| Support Level | $1.21 | $18.64 |
| Resistance Level | $1.42 | $18.98 |
| Average True Range (ATR) | 0.07 | 0.36 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 85.48 | 1.18 |
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.